Unlock instant, AI-driven research and patent intelligence for your innovation.

Method and kit for identifying state of liver cancer

A kit, technology for liver cancer, applied in the directions of biochemical equipment and methods, microbial determination/examination, DNA/RNA fragments, etc.

Pending Publication Date: 2022-01-07
BEIJING EXELLON MEDICAL TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is still a lack of means to effectively detect the methylation status of these cancer-related genes and process the detection results

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and kit for identifying state of liver cancer
  • Method and kit for identifying state of liver cancer
  • Method and kit for identifying state of liver cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0078] Example 1: DNA Extraction

[0079] DNA Extraction Reagent consists of Lysis Buffer, Binding Buffer, Washing Buffer and Elution Buffer. Lysis buffer consists of protein denaturants, detergents, pH buffers and nuclease inhibitors. Binding buffers consist of protein denaturants and pH buffers. The cleaning buffer is divided into cleaning buffer A and cleaning buffer B, and cleaning buffer A is composed of protein denaturant, nuclease inhibitor, detergent, pH buffer and ethanol; cleaning buffer B is composed of nuclease inhibitor, pH buffer and ethanol composition. The elution buffer consists of nuclease inhibitors and pH buffers. The protein denaturant is: guanidine hydrochloride; the detergent is: Tween20; the pH buffer is: Tris-HCl; the nuclease inhibitor is: EDTA.

[0080] This embodiment takes the plasma sample of a liver cancer patient as an example to extract plasma DNA. The extraction method comprises the following steps:

[0081] (1) Take 1 mL of plasma, add ...

Embodiment 2

[0093] Example 2: Bisulfite Treatment of DNA

[0094] Bisulfite treatment of DNA is to use bisulfite reagent to treat the extracted DNA sample. The bisulfite reagent is composed of bisulfite buffer and protection buffer; the bisulfite buffer is bisulfite A mixture of sodium and water; the protection buffer is a mixture of hydroquinone, an oxygen free radical scavenger, and water.

[0095] In this embodiment, the DNA extracted in Example 1 is used as the processing object, and the DNA is treated with bisulfite, and the specific steps include:

[0096] (1) Preparation of bisulfite buffer: weigh 1g of sodium bisulfite powder, add water to prepare 3M buffer;

[0097] (2) Preparation of protection buffer: weigh 1g of hydroquinone reagent, add water to prepare 0.5M protection buffer;

[0098] (3) Mix 100 μL DNA solution, 200 μl bisulfite buffer solution and 50 μL protection solution, shake and mix evenly;

[0099] (4) Thermal cycle: 95°C for 5 minutes, 80°C for 60 minutes, 4°C fo...

Embodiment 3

[0110] Embodiment 3: Detection of DNA methylation level by real-time fluorescent PCR

[0111]In this embodiment, real-time fluorescent PCR is used as an example to detect the methylation level of DNA methylation marker genes. The DNA methylation marker genes detected were BMP4, COX2, EMX1, Septin9, SOCS1 and TSPYL5 genes, and the internal reference gene was ACTB. We have designed a variety of primers and probes, which can be identical to, complementary to or hybridize to the sequence shown in SEQ ID NO: 1-6 or its complementary sequence (treated with bisulfite), respectively. The sequence of the primer set is as follows:

[0112] BMP4 Primer Set 1

[0113] Primer 1: SEQ ID NO 7: 5'-GAACGCGTTGTTTACGGGTTGGAGG-3'

[0114] Primer 2: SEQ ID NO 8: 5'-TCCCCATCTCGCCGTCGCTCT-3'

[0115] Blocking primer: SEQ ID NO 9: 5'-TGTGTTGTTTATGGGTTGGAGGTTGTGATT-C3-3'

[0116] Probe: SEQ ID NO 10: 5'-FAM-TTCCTCCTCCCGCGCTTTCCGTCCG-BHQ1-3'

[0117] BMP4 Primer Set 2

[0118] Primer 1: SEQ ID NO...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for identifying the state of liver cancer. The method comprises the following steps of 1) detecting the methylation level of a biomarker gene in a biological sample from a subject, wherein the biomarker gene comprises one or more of BMP4, COX2, EMX1, Septin9, SOCS1 and TSPYL5 genes; and 2) comparing the methylation level detected in the step 1) with the normal methylation level of a corresponding biomarker in a group to determine the state of the liver cancer f the subject. The invention further provides a kit for identifying the state of the liver cancer. The method and the kit provided by the invention provide a rapid, reliable and accurate new way for predicting, diagnosing and evaluating the liver cancer.

Description

technical field [0001] This article relates to methods and kits for identifying liver cancer status in subjects, especially methods and kits for identifying liver cancer status by using the methylation level of biomarker genes. Background technique [0002] Primary liver cancer (PLC), referred to as liver cancer, is a common malignant tumor of the digestive system worldwide. According to the new data released by GLOBOCAN in 2018, the annual number of new cases of liver cancer worldwide reached 841,000, ranking sixth among malignant tumors, and 782,000 died, ranking second among malignant tumors. The incidence of primary liver cancer is particularly high in my country, and it is the fourth most common malignant tumor and the second leading cause of tumor death. my country's population only accounts for 18.4% of the world's total, but the number of new liver cancer cases reaches 466,000 and the death rate reaches 422,000, accounting for 55.4% and 53.9% of the global total res...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6886C12Q1/6858C12N15/11
CPCC12Q1/6886C12Q1/6858C12Q2600/112C12Q2600/154C12Q2600/166C12Q2523/125C12Q2531/113C12Q2563/107C12Q2545/101
Inventor 徐春叶李明明蒲珏
Owner BEIJING EXELLON MEDICAL TECH CO LTD